Dr. Carolyn Myers reports

FENDX ENGAGES INNOVOTECH FOR REGULATORY PATHWAY ASSESSMENT OF ITS COATED FOLEY CATHETER PROGRAM

Fendx Technologies Inc. has entered into an agreement dated April 28, 2026, with Innovotech Labs Corp. to support regulatory planning for its coated catheter program.

Under the agreement, Innovotech will conduct regulatory research to determine the appropriate U.S. Food and Drug Administration classification and regulatory pathway for Fendx's coated Foley catheter product currently in development. The scope of work will include an assessment of regulatory requirements outlining the recommended FDA regulatory pathway.

Dr. Carolyn Myers, chief executive officer of Fendx, stated: "Engaging Innovotech to evaluate the FDA regulatory pathway is an important step in advancing our coated Foley catheter program toward commercialization. Establishing a clear and efficient regulatory strategy is critical as we continue development of this technology, which is being designed to reduce bacterial growth and infection risk associated with Foley catheter use."

Dr. Myers continued, "Following determination of the regulatory pathway, a next step will be to conduct anti-microbial testing, and the company would potentially engage Innovotech to provide these services using their advanced methodologies to produce application-specific data to support our further development efforts."

About Fendx Technologies Inc.

Fendx is a surface protection company developing innovative solutions to help reduce the spread of harmful pathogens in everyday environments. Leveraging proprietary technologies, the company is advancing a portfolio of protective surface coatings, including a liquid-based nano-coating technology and a specialized Foley catheter coating. The company is focused on building a robust intellectual property portfolio in the surface protection space, and is committed to identifying and advancing new technologies and materials that enhance hygiene and safety across health care, consumer and commercial settings.

We seek Safe Harbor.